| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |